A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Structured Literature Review and International Consensus Validation of FORTA Labels of Oral Anticoagulants for Long-Term Treatment of Atrial Fibrillation in Older Patients (OAC-FORTA 2019)
Authors
Keywords
-
Journal
DRUGS & AGING
Volume 37, Issue 7, Pages 539-548
Publisher
Springer Science and Business Media LLC
Online
2020-06-05
DOI
10.1007/s40266-020-00771-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Net Clinical Benefit of Non-Vitamin K Antagonist Versus Vitamin K Antagonist Anticoagulants in Elderly Patients With Atrial Fibrillation
- (2019) Giuseppe Patti et al. AMERICAN JOURNAL OF MEDICINE
- Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation
- (2019) Renato D. Lopes et al. NEW ENGLAND JOURNAL OF MEDICINE
- The FORTA (Fit fOR The Aged) List 2018: Third Version of a Validated Clinical Tool for Improved Drug Treatment in Older People
- (2019) Farhad Pazan et al. DRUGS & AGING
- Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF
- (2019) Sylvia Haas et al. AMERICAN HEART JOURNAL
- The U.S.-FORTA (Fit fOR The Aged) List: Consensus Validation of a Clinical Tool to Improve Drug Therapy in Older Adults
- (2019) Farhad Pazan et al. Journal of the American Medical Directors Association
- Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial
- (2019) Pascal Vranckx et al. LANCET
- Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
- (2018) Meena P. Rao et al. AMERICAN JOURNAL OF MEDICINE
- The EURO-FORTA (Fit fOR The Aged) List: International Consensus Validation of a Clinical Tool for Improved Drug Treatment in Older People
- (2018) Farhad Pazan et al. DRUGS & AGING
- Net clinical benefit of rivaroxaban compared with warfarin in atrial fibrillation: Results from ROCKET AF
- (2018) Adam S. Barnett et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effectiveness and Safety of Non–Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation
- (2018) Edin Basic et al. THROMBOSIS AND HAEMOSTASIS
- Effects of dabigatran according to age in atrial fibrillation
- (2017) Mandy N Lauw et al. HEART
- 5-Year Outcomes After Left Atrial Appendage Closure
- (2017) Vivek Y. Reddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation
- (2017) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification
- (2016) Martin Wehling et al. AGE AND AGEING
- Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment StrategyClinical Perspective
- (2016) C. Michael Gibson et al. CIRCULATION
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Edoxaban Versus Warfarin in Atrial Fibrillation Patients at Risk of Falling
- (2016) Jan Steffel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI
- (2016) C. Michael Gibson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine
- (2016) John H. Alexander et al. JAMA Cardiology
- Epidemiology of atrial fibrillation: European perspective
- (2014) Massimo Zoni-Berisso et al. Clinical Epidemiology
- Consensus Validation of the FORTA (Fit fOR The Aged) List: A Clinical Tool for Increasing the Appropriateness of Pharmacotherapy in the Elderly
- (2013) Alexandra M. Kuhn-Thiel et al. DRUGS & AGING
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- MULTIMORBIDITY AND POLYPHARMACY: HOW TO REDUCE THE HARMFUL DRUG LOAD AND YET ADD NEEDED DRUGS IN THE ELDERLY? PROPOSAL OF A NEW DRUG CLASSIFICATION: FIT FOR THE AGED
- (2009) Martin Wehling JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Arzneimitteltherapie im Alter: Zu viel und zu wenig, was tun?
- (2008) M Wehling DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now